Autolus Therapeutics
Stock Forecast, Prediction & Price Target
Autolus Therapeutics (AUTL) stock Price Target by analysts
$7.6
Potential upside: 326.94%
Autolus Therapeutics price prediction
What is Autolus Therapeutics stock analysts` prediction?
Autolus Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Autolus Therapeutics in the last 3 months, the avarage price target is $7.6, with a high forecast of $NaN. The average price target represents a 326.94% change from the last price of $1.78.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Autolus Therapeutics stock Price Target by analysts
Full breakdown of analysts given Autolus Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Graig Suvannavejh Goldman Sachs | 0% 0/1 | 10 months ago | $7.6 326.94% upside | $3.03 | StreetInsider | Previous targets (0) |
Yanan Zhu Wells Fargo | 0% 0/1 | over 1 year ago | $8 349.41% upside | $4.39 | StreetInsider | Previous targets (0) |
Asthika Goonewardene Truist Financial | 0% 0/2 | over 1 year ago | $11 517.94% upside | $5.53 | StreetInsider | Previous targets (1) |
Asthika Goonewardene Truist Financial | 0% 0/2 | over 1 year ago | $10 461.76% upside | $5.82 | StreetInsider | Previous targets (1) |
Autolus Therapeutics Financial Estimates
Autolus Therapeutics Revenue Estimates
Autolus Therapeutics EBITDA Estimates
Autolus Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $2.33M N/A | $6.19M 165.83% | $1.69M -72.58% | Avg: $73.35M Low: $47.71M High: $109.16M avg. 4220.03% | Avg: $174.66M Low: $87.24M High: $322.37M avg. 138.11% | Avg: $397.46M Low: $198.53M High: $733.56M avg. 127.55% | Avg: $564.20M Low: $281.81M High: $1.04B avg. 41.95% |
Net Income
% change YoY
| $-142.09M N/A | $-148.83M -4.74% | $-208.38M -40.00% | Avg: $-138.51M Low: $-142.63M High: $-55.66M avg. 33.52% | Avg: $-67.62M Low: $-124.15M High: $95.66M avg. 51.17% | Avg: $19.43M Low: $6.79M High: $40.81M avg. 128.74% | Avg: $77.39M Low: $27.03M High: $162.47M avg. 298.12% |
EBITDA
% change YoY
| $-155.74M N/A | $-156.36M -0.39% | $-156.77M -0.26% | Avg: $-73.35M Low: $-109.16M High: $-47.71M avg. 53.20% | Avg: $-174.66M Low: $-322.37M High: $-87.24M avg. -138.11% | Avg: $-397.46M Low: $-733.56M High: $-198.53M avg. -127.55% | Avg: $-564.20M Low: $-1.04B High: $-281.81M avg. -41.95% |
EPS
% change YoY
| -$1.97 N/A | -$1.57 20.30% | -$1.2 23.56% | Avg: -$0.57 Low: -$0.82 High: -$0.32 avg. 52.89% | Avg: -$0.22 Low: -$0.71 High: $0.55 avg. 60.30% | Avg: $0.11 Low: $0.04 High: $0.23 avg. 149.81% | Avg: $0.44 Low: $0.16 High: $0.93 avg. 298.12% |
Operating Expenses
% change YoY
| $166.65M N/A | $173.72M 4.24% | $1.69M -99.02% | Avg: $2.94B Low: $1.91B High: $4.37B avg. 173192.47% | Avg: $7.00B Low: $3.49B High: $12.93B avg. 138.11% | Avg: $15.94B Low: $7.96B High: $29.42B avg. 127.55% | Avg: $22.63B Low: $11.30B High: $41.77B avg. 41.95% |
FAQ
What is Autolus Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 127.89% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -142.63M, average is -138.51M and high is -55.66M.
What is Autolus Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1131.91% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $47.71M, average is $73.35M and high is $109.16M.
What is Autolus Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 140.28% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$0.82, average is -$0.57 and high is $-0.32.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Autolus Therapeutics stock. The most successful analyst is Graig Suvannavejh.